(Press-News.org) A major study has found that people with eczema are able to bathe either daily or weekly, without any impact to their symptoms.
The findings of the new study, which are published in the British Journal of Dermatology, are great news for people living with eczema, as it will mean they will have the freedom to choose how often to bathe without fear it will worsen their symptoms.
People with eczema often have questions about how best to bathe including how often to have a bath or shower. The ‘Eczema Bathing study’, was prioritised and developed by people living with eczema, in partnership with researchers from the University of Nottingham and Nottingham University Hospitals NHS Trust. The research was funded by the National Institute for Health and Care Research (NIHR).
The study compared daily bathing – having a bath or shower six or more times a week, with weekly bathing – having a bath or shower one or two times a week.
438 people living with eczema from across the UK took part in the study, which included both adults and children. Everyone was put into one of the two groups at random to help ensure that the two groups were as similar as possible. Those taking part continued using their usual treatments during the study and recorded their eczema symptoms each week for 4 weeks.
Overall, the results showed there was no difference in eczema symptoms between the two groups.
Lucy Bradshaw, Lead Author, and Senior Medical Statistician at Nottingham Clinical Trials Unit, at the University of Nottingham, said: “The findings of our study are great news for people living with eczema. It means they can choose a frequency of bathing that suits them. It was fantastic to work so closely with people living with eczema to co‑design this study. Together, we're starting to answer questions about living with eczema that haven’t had enough attention in research until now.”
Amanda Roberts, an eczema patient and carer and Co-Chief Investigator, said: “There are so many things in everyday life which have the potential to affect eczema. It is good to know frequency of bathing or showering is not one of them. One less thing to worry about.”
The Eczema Bathing Study is the first study completed as part of a wider five-year project that started in 2022 – the Rapid Eczema Trials research project - that aims to answer important questions on how to manage eczema. The Rapid Eczema Trials citizen science project has built an Eczema Citizen Science Community who are working together to design and run a series of online research studies. People are being encouraged to join the community from across the UK. The next study is looking at how long to use steroid creams to treat flare-ups to help keep control of eczema.
The Rapid Eczema Trials research project is led by researchers at the University of Nottingham and Nottingham University Hospitals NHS Trust, and is being delivered in collaboration with another four UK Universities (Southampton, Bristol, Birmingham City, Imperial) and the Nottingham Clinical Trials Unit
Matthew Ridd, GP, Co-applicant and Professor of Primary Health Care, at the University of Bristol, said: “How often to have a bath or shower is such a simple but important issue that people with eczema often ask health care professionals for advice on. The Rapid Eczema Trials project has provided everyone with the best, evidence-based answer to this practical question.”
Professor Marian Knight, Scientific Director for NIHR Infrastructure and Director of NIHR Programme Grants for Applied Research said: “This study shows the value of the NIHR’s approach to putting patients and the public at the heart of everything we do. By working with people who live with eczema, the research team has been able to answer a question that has affected people's quality of life for years. The research shows that how often you bathe does not make a difference to symptoms, giving people the freedom to make the choice that is best for them. This is exactly what our research funding is about, giving people the answers they need to better understand and manage their own health.”
END
New study gives people with eczema freedom to choose how often to bathe
2025-11-10
ELSE PRESS RELEASES FROM THIS DATE:
Children’s dental health still very poor despite interventions
2025-11-10
Children's access to NHS dentists and rates of tooth decay remain very poor despite improvements from national government interventions, oral health experts say.
Analysis of the latest government data by the Child of the North initiative gives cause for cautious optimism, they say, but the schemes need to be scaled up and strengthened to meet the needs of young people across the country.
The latest update, titled Improving Children’s Oral Health Update: Integrated Health and Education Solutions, is the seventh to be released ...
Hospital patients who feel short of breath are six times more likely to die
2025-11-10
The risk of dying is six times higher among patients who become short of breath after being admitted to hospital, according to research published today (Monday) in ERJ Open Research [1]. Patients who were in pain were not more likely to die.
The study of nearly 10,000 people suggests that asking patients if they are feeling short of breath could help doctors and nurses to focus care on those who need it most.
The study is the first of its kind and was led by Associate Professor Robert Banzett from Beth Israel Deaconess Medical Center, Harvard Medical School, ...
Existing evidence does not clearly link paracetamol use during pregnancy with autism or ADHD in children
2025-11-10
Existing evidence does not clearly link paracetamol (acetaminophen) use during pregnancy with autism or ADHD in children, finds an in-depth evidence review published by The BMJ today, in direct response to recent announcements around the safety of using paracetamol in pregnancy.
The researchers say confidence in the findings of existing evidence reviews and studies on this topic is low to critically low, and suggest that any apparent effect seen in previous studies may be driven by shared genetic and environmental factors within families.
Regulatory bodies, clinicians, pregnant women, parents, and those affected by autism and ADHD should be informed ...
Should kids be screened for high cholesterol genes?
2025-11-09
Nov. 9, 2025--In the United States, one in every 250 people has inherited a genetic variant that leads to dangerously high cholesterol levels from birth.
If high cholesterol isn’t lowered early, people with this genetic condition, called familial hypercholesterolemia (FH), have a high risk of having a heart attack or stroke as early as their 30s or 40s. But only about 1 in 10 of people living with FH (1.5 million Americans) is aware of their condition.
A new modeling study conducted by researchers at Columbia and Harvard Universities finds ...
Weight loss drugs don’t increase the risk of pancreatitis or adverse cardiac events in patients with high triglycerides
2025-11-09
In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used by patients who have high triglycerides do not increase their risk of pancreatitis or adverse cardiac events.
Since the first GLP-1 receptor agonists (GLP1RAs), more commonly known now as weight loss drugs, were approved in 2005, some clinicians have been hesitant to prescribe them to people who have very high triglycerides. That’s because these patients are typically at high risk of pancreatitis, and the drugs interact with the pancreas.
In the new study, Intermountain researchers found that ...
Major international study confirms that beta-blockers are no longer needed in post-infarction patients with normal heart function
2025-11-09
A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international institutions, has pooled data from 17,801 myocardial infarction survivors with preserved cardiac function enrolled in five global clinical trials. The study concludes that beta-blockers offer no clinical benefit for this patient group, which today represents the majority of infarction survivors. The study was made possible by close collaboration between CNIC researchers and the ...
Targeted vitamin D3 supplementation cuts risk of heart attack patients having a second heart attack in half, new intermountain health study finds
2025-11-09
A tailored approach of vitamin D3 supplementation in patients who have suffered a heart attack significantly reduces their risk of a second heart attack, a new study from heart researchers at Intermountain Health in Salt Lake City finds.
In a large, randomized clinical trial, Intermountain Health researchers have found that treating heart attack patients in a “target to treat” fashion, where patients’ blood levels of vitamin D were monitored and vitamin D3 dosing adjusted to achieve optimal levels, cut their risk of a second heart attack in half.
Results of the study were presented on Nov. 9 at the 2025 American Heart Association Scientific ...
Any form of hypertension during pregnancy significantly increases postpartum cardiovascular risk including death, new study finds
2025-11-09
A new study from researchers at Intermountain Health reveals that hypertensive disorders of pregnancy (HDP) significantly increase the risk of cardiovascular complications — including heart attack, stroke, heart failure, and death — within five years of giving birth.
The study found that women who experienced HDP during pregnancy were significantly more likely to develop serious cardiovascular-related issues compared to those without HDP. These findings underscore the growing body of evidence over the past two decades linking pregnancy-related hypertension to ...
Opening all blocked arteries with stents reduces risk of death from cardiovascular causes compared with opening only the culprit artery in heart attack patients
2025-11-09
Opening all blocked arteries with stents in patients with a heart attack, known as complete revascularization, reduces the risk of death from cardiovascular causes, death from any cause and future heart attacks compared with opening only culprit artery causing the heart attack according to a new, large international study led by researchers at the Population Health Research Institute (PHRI), a joint organization of McMaster University and Hamilton Health Sciences.
The results were published simultaneously in The Lancet and presented in a Late-Breaking Clinical Science Featured Research ...
More prenatal visits linked to right level of care for infants born with heart defects
2025-11-09
In cases of mild congenital heart defects, more prenatal visits are associated with greater likelihood of appropriate delivery at a community hospital, according to a study published in JAMA Network Open. Results suggest that more prenatal care is beneficial for families and may allow their newborns with mild heart defects to receive the right level of care closer to home, as opposed to traveling to a regional cardiac surgical center, which can be expensive, taxing and stressful for families.
Congenital heart defects are the most common and resource-intensive birth defects in the United States. Infants with the most complex heart defects are usually directed ...